Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
SurModics (SRDX) PT Lowered to $70 at Needham & Company
November 10, 2021 12:10 PM ESTNeedham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $70.00 (from $76.00) while maintaining a Buy rating.
The analyst commented, "SRDX's F4Q21 revenue and EPS beat consensus. Initial FY22 revenue and EPS guidance was well below consensus... More
SurModics (SRDX) Tops Q4 EPS by 15c
November 10, 2021 7:37 AM ESTSurModics (NASDAQ: SRDX) reported Q4 EPS of ($0.10), $0.15 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $24 million versus the consensus estimate of $23.06 million.
GUIDANCE:
SurModics sees FY2022 EPS of ($1.75)-($1.25), versus the consensus of $0.21. SurModics sees... More



